Avoid. GENI scores 31/100 with a weak Value Compounder Score (13/100) indicating limited earnings power and cash generation relative to valuation. Leadership Alignment (46.5/100) reflects moderate founder involvement without decisive ownership concentration to align incentives. Vulnerability Profile shows adequate financial buffer but no structural moat—the company lacks durable competitive advantages to justify risk.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for GENI:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 31/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates GENI (GENI) at 31/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. GENI scores 31/100 with a weak Value Compounder Score (13/100) indicating limited earnings power and cash generation relative to valuation. Leadership Alignment (46.5/100) reflects moderate founder involvement without decisive owners
GENI's current Stocky Verdict is 31/100, placing it in the "Avoid" band. This composite combines a 13/100 Compounder score, 47/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for GENI yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
GENI scores 47/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
GENI's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to GENI.
Sign up free and unlock the full analysis on GENI — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
Or jump straight to the interactive dashboard for GENI in the app.
